Stem cell therapy for heart disease: truly beneficial?
作者信息
van der Wall E E
机构信息
Interuniversity Cardiology Institute of the Netherlands (ICIN), Netherlands Heart Institute, Catherijnesingel 52, P.O. Box 19258, 3501 DG, Utrecht, the Netherlands,
出版信息
Neth Heart J. 2014 Aug;22(7-8):313-5. doi: 10.1007/s12471-014-0568-2.
Abstract
摘要
相似文献
1
Stem cell therapy for heart disease: truly beneficial?干细胞疗法治疗心脏病：真的有益吗？
Neth Heart J. 2014 Aug;22(7-8):313-5. doi: 10.1007/s12471-014-0568-2.
2
Autologous cell based therapy for treating chronic infarct myocardium.用于治疗慢性梗死心肌的自体细胞疗法。
Clin Hemorheol Microcirc. 2005;33(3):263-8.
3
Do stem cells in the heart truly differentiate into cardiomyocytes?心脏中的干细胞真的能分化为心肌细胞吗？
J Mol Cell Cardiol. 2007 Oct;43(4):377-87. doi: 10.1016/j.yjmcc.2007.07.056. Epub 2007 Jul 31.
4
Enhancement Strategies for Cardiac Regenerative Cell Therapy: Focus on Adult Stem Cells.心脏再生细胞治疗的增强策略：以成体干细胞为重点。
Circ Res. 2018 Jul 6;123(2):177-187. doi: 10.1161/CIRCRESAHA.118.311207.
5
Clinical applications of stem cells for the heart.干细胞在心脏方面的临床应用。
Circ Res. 2005 Feb 4;96(2):151-63. doi: 10.1161/01.RES.0000155333.69009.63.
6
Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.用于慢性缺血性心脏病和充血性心力衰竭的干细胞疗法。
Cochrane Database Syst Rev. 2014 Apr 29(4):CD007888. doi: 10.1002/14651858.CD007888.pub2.
7
Stem cell therapy for heart disease.干细胞治疗心脏病。
J Gen Intern Med. 2013 Oct;28(10):1353-63. doi: 10.1007/s11606-013-2508-z. Epub 2013 Jun 15.
8
Stem cell therapy for end-stage heart failure: indispensable role for the cell?干细胞治疗终末期心力衰竭：细胞的不可或缺作用？
Curr Opin Organ Transplant. 2009 Oct;14(5):560-5. doi: 10.1097/MOT.0b013e328330389e.
9
Wnt Signaling: The double-edged sword diminishing the potential of stem cell therapy in congenital heart disease.Wnt 信号通路：双刃剑削弱了干细胞疗法在先天性心脏病中的应用潜力。
Life Sci. 2019 Dec 15;239:116937. doi: 10.1016/j.lfs.2019.116937. Epub 2019 Oct 17.
10
In Search of the Holy Grail: Stem Cell Therapy as a Novel Treatment of Heart Failure with Preserved Ejection Fraction.探寻圣杯：干细胞疗法作为射血分数保留心力衰竭的新型治疗方法。
Int J Mol Sci. 2023 Mar 3;24(5):4903. doi: 10.3390/ijms24054903.
引用本文的文献
1
Reaching out: junctions between cardiac telocytes and cardiac stem cells in culture.建立联系：培养中的心脏间充质干细胞与心脏干细胞之间的连接
J Cell Mol Med. 2016 Feb;20(2):370-80. doi: 10.1111/jcmm.12719. Epub 2015 Nov 5.
本文引用的文献
1
Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis.自体骨髓干细胞试验与射血分数改善的差异（DAMASCENE）：加权回归和荟萃分析。
BMJ. 2014 Apr 28;348:g2688. doi: 10.1136/bmj.g2688.
2
The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE).C-CURE随机临床试验（心力衰竭中的心脏干细胞治疗）
J Am Coll Cardiol. 2013 Dec 24;62(25):2453. doi: 10.1016/j.jacc.2013.09.013.
3
Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.冠状动脉内骨髓细胞治疗对ST段抬高型心肌梗死患者左心室功能的影响：一项协作荟萃分析。
Eur Heart J. 2014 Apr;35(15):989-98. doi: 10.1093/eurheartj/eht372. Epub 2013 Sep 11.
4
Autologous bone marrow-derived stem cell therapy in heart disease: discrepancies and contradictions.自体骨髓源性干细胞治疗心脏病：差异与矛盾。
Int J Cardiol. 2013 Oct 9;168(4):3381-403. doi: 10.1016/j.ijcard.2013.04.152. Epub 2013 Jul 2.
5
Cardiomyogenesis in the aging and failing human heart.衰老和衰竭人心肌生成。
Circulation. 2012 Oct 9;126(15):1869-81. doi: 10.1161/CIRCULATIONAHA.112.118380. Epub 2012 Sep 6.
6
Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe?经皮冠状动脉介入治疗（PCI）后心肌梗死后单核细胞冠状动脉内输注与心律失常发生：安全吗？
Neth Heart J. 2012 Mar;20(3):133-7. doi: 10.1007/s12471-012-0251-4.
7
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.缺血性心肌病患者的心脏干细胞（SCIPIO）：一项随机 1 期试验的初步结果。
Lancet. 2011 Nov 26;378(9806):1847-57. doi: 10.1016/S0140-6736(11)61590-0. Epub 2011 Nov 14.
8
Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.急性心肌梗死后行直接经皮冠状动脉介入治疗患者中，与标准治疗相比，骨髓或外周血单核细胞冠状动脉内输注：随机对照 HEBE 试验的结果。
Eur Heart J. 2011 Jul;32(14):1736-47. doi: 10.1093/eurheartj/ehq449. Epub 2010 Dec 10.
9
10
Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.心肌内注射骨髓细胞治疗慢性心肌缺血：一项随机对照试验。
JAMA. 2009 May 20;301(19):1997-2004. doi: 10.1001/jama.2009.685.
Zotero 插件